These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8388527)

  • 1. [Low-molecular-weight heparins].
    Rocha E; Páramo JA; Sarrá J
    Med Clin (Barc); 1993 Apr; 100(16):620-7. PubMed ID: 8388527
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommendations on biosimilar low-molecular-weight heparins.
    Harenberg J; Kakkar A; Bergqvist D; Barrowcliffe T; Casu B; Fareed J; Mismetti P; Ofosu FA; Raake W; Samama M; Schulman S;
    J Thromb Haemost; 2009 Jul; 7(7):1222-5. PubMed ID: 19323788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low molecular weight heparins].
    Taurand S
    Soins; 1990 Dec; (543):I-II. PubMed ID: 1965350
    [No Abstract]   [Full Text] [Related]  

  • 4. Symposium on low molecular weight heparins (LMW heparins).
    Samama MM; Monasterio J
    Haemostasis; 1996; 26 Suppl 2():1. PubMed ID: 8707161
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations?
    Zakarija A; Bennett CL
    Arch Intern Med; 2005 Apr; 165(7):722-3. PubMed ID: 15824289
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical uses for low-molecular-weight heparins.
    Wise GR
    West J Med; 1996 May; 164(5):440. PubMed ID: 8686303
    [No Abstract]   [Full Text] [Related]  

  • 7. [Standard heparin and low molecular weight heparins].
    Chojnowski K; Judkiewicz L; Sobol A
    Acta Haematol Pol; 1992; 23(4):207-12. PubMed ID: 1338174
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology of thromboembolism and its modulation by low-molecular-weight heparins.
    Breddin HK
    Semin Thromb Hemost; 1996; 22 Suppl 1():25-7. PubMed ID: 8807725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparins: the future of thromboembolic therapy.
    Dobbin KR
    Nurse Pract; 1998 Mar; 23(3):98,101-4,106-7. PubMed ID: 9560832
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins].
    Lobato-Mendizábal E; Majluf-Cruz A
    Rev Invest Clin; 2000; 52(5):529-45. PubMed ID: 11195182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Low molecular weight heparins: mechanisms of action and pharmococynetics. Clinical advantages over the classic unfractioned heparins].
    Campos M
    Rev Port Cir Cardiotorac Vasc; 2003; 10(2):61-7. PubMed ID: 15094887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of the low-molecular-weight heparins.
    Fareed J; Hoppensteadt DA
    Semin Thromb Hemost; 1996; 22 Suppl 2():13-8. PubMed ID: 8946614
    [No Abstract]   [Full Text] [Related]  

  • 15. [Low-molecular-weight heparin. Prophylaxis and treatment of thromboembolisms in surgery and obstetrics].
    Nikolov A; Kovachev I; Petkov Iu; Dimitrov A
    Akush Ginekol (Sofiia); 2000; 39(3):35-40. PubMed ID: 11187995
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathophysiology of thromboembolism and its modulation by low molecular weight heparins.
    Breddin HK
    Semin Thromb Hemost; 1993; 19 Suppl 1():227-8. PubMed ID: 8395726
    [No Abstract]   [Full Text] [Related]  

  • 17. [Low molecular weight heparin--1998 status].
    Marbet GA
    Praxis (Bern 1994); 1999 Apr; 88(18):802-7. PubMed ID: 10409877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current indications of low-molecular-weight heparins].
    Vignes S; Meyer G; Marjanovic Z; Farge-Bancel D
    Ann Med Interne (Paris); 1997; 148(2):154-62. PubMed ID: 9238441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-molecular-weight heparins].
    Ostermann H
    Internist (Berl); 1998 Apr; 39(4):414-5. PubMed ID: 9599756
    [No Abstract]   [Full Text] [Related]  

  • 20. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.
    Bick RL; Frenkel EP; Walenga J; Fareed J; Hoppensteadt DA
    Hematol Oncol Clin North Am; 2005 Feb; 19(1):1-51, v. PubMed ID: 15639107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.